Evaluation of Brimonidine Tartrate/Ketotifen Fumarate Combination in Adults With Seasonal Allergic Conjunctivitis
Public ClinicalTrials.gov record NCT05591755. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Evaluation of the Combination Drug Product Brimonidine Tartrate 0.025%/Ketotifen Fumarate 0.035% Ophthalmic Solution Compared to Its Components and Vehicle in an Allergen BioCube® in Subjects With Seasonal Allergic Conjunctivitis
Study identification
- NCT ID
- NCT05591755
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Bausch & Lomb Incorporated
- Industry
- Enrollment
- 229 participants
Conditions and interventions
Conditions
Interventions
- Brimonidine Tartrate 0.025%/ Ketotifen Fumarate 0.035% Ophthalmic Solution Drug
- Ketotifen fumarate ophthalmic solution 0.035% Drug
- Brimonidine tartrate ophthalmic solution 0.025% Drug
- Experimental: Vehicle ophthalmic solution Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 17, 2022
- Primary completion
- Aug 8, 2023
- Completion
- Aug 8, 2023
- Last update posted
- Jun 30, 2025
2022 – 2023
United States locations
- U.S. sites
- 6
- U.S. states
- 4
- U.S. cities
- 6
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| 104 Butchertown Clinical Trials | Louisville | Kentucky | 40206 | — |
| 101 Andover Eye Associates | Andover | Massachusetts | 01810 | — |
| 105 - Advancing Vision Research | Goodlettsville | Tennessee | 37072 | — |
| 102 Total Eye Care, PA | Memphis | Tennessee | 38119 | — |
| 108 Emerson Clinical Research Institute Inc. | Falls Church | Virginia | 22046 | — |
| 107 Virginia Eye Institute | Richmond | Virginia | 23230 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05591755, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 30, 2025 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05591755 live on ClinicalTrials.gov.